Document Type : Research Article
Abstract
Brief Summary:
The main aim of the study is to assess whether Rhodiola rosea in the potency C 1-4 nitites more
characteristic homeopathic symptoms during proving after three days upto one week, compared
to a placebo in Hypertensive and Anxiety/ Depression prone volunteers.
Secondary aims are to develop and to test a qualitative analysis methodology on which to base a
definition for drug-specific (characteristic) symptoms and to compile a profile of characteristic
homeopathic proving symptoms of the drug being trialed for therapeutic purposes.
This study protocol adapts the traditional homeopathic drug proving methodology to a modern
clinical trial design.
)